Control Bionics (ASX:CBL) Looks to Solidify Global Presence
April 19, 2021
Rob Wong, CEO of Control Bionics, chats with Alan Kohler from Eureka Report to discuss the latest news from the newly ASX-listed business. ” …
Menu
Rob Wong, CEO of Control Bionics, chats with Alan Kohler from Eureka Report to discuss the latest news from the newly ASX-listed business. ” …
Strategic Partnership Offers Customers More Access to Control Bionics’ Industry-Leading Trilogy Product Line. (Milford, OH and New South Wales, AU) – Control Bionics, a global assistive
Medtech company Control Bionics (ASX:CBL) will list on the ASX next week. The company’s EMG (electromyography)-based technology helps people with disabilities inhibiting communications to do so
Control Bionics Launches World-Class Multi-Modal Augmentative and Alternative Communications (AAC) Device for Those with Speech and Motor Disorders With Unique Combination of Technologies, New GridPad
To Our Clients, Caregivers, and Clinicians: As we’ve globally transitioned into telepresence communication, we will still be offering our remote assessments alongside our industry-leading customer
Your NeuroNode Trilogy should be cleaned and disinfected on a regular basis. We recommend Super Sani-Cloth Germicidal Disposable Wipes for this. While Control Bionics routinely
Control Bionics was founded by Peter Shann Ford in 2006 to address the most difficult cases of loss of speech and mobility. Ford and the
The NeuroNode Trilogy provides three access methods in a single funding accessible solution for degenerative conditions. MILFORD, OH – Feb.5, 2019 – Control Bionics Launches
Successful NeuroNode Performance Trial with Maeve, a 3rd Grade Student with Spinal Muscular Atrophy (SMA), Leads to Acquisition of seven NeuroNodes by NYC DOE’s Center for
Not finding what you’re looking for? Contact us
USA
745 Center Street, Suite 303
Milford OH 45150
AUSTRALIA
171 Union Road, Suite G.03
Surrey Hills VIC 3127
CANADA
Bridges Canada
2123 McCowan Road
Scarborough, Ontario M1S 3Y6
©2012-2021 Control Bionics, Inc. All Rights Reserved
